Fig. 2From: Cytoreductive surgery offers prognostic benefits in metastatic gastrointestinal stromal tumors with generalized progression following imatinib therapy: a single institute retrospective studyA and B show PFS and OS from the date of CRS by the extent of resection (R0/1 or R2). C shows OS from the date of imatinib initiation by the extent of resectionBack to article page